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Butyrate production in the large intestine and ruminant forestomach depends on bacterial butyryl-CoA/acetate-
CoA transferase activity and is highest when fermentable fiber and nonstructural carbohydrates are balanced.
Gastrointestinal epithelia seem to use butyrate and butyrate-induced endocrine signals to adapt proliferation,
apoptosis, and differentiation to the growth of the bacterial community. Butyrate has a potential clinical application
in the treatment of inflammatory bowel disease (IBD; ulcerative colitis). Via inhibited release of tumor necrosis factor
α and interleukin 13 and inhibition of histone deacetylase, butyrate may contribute to the restoration of the tight
junction barrier in IBD by affecting the expression of claudin-2, occludin, cingulin, and zonula occludens poteins
(ZO-1, ZO-2). Further evaluation of the molecular events that link butyrate to an improved tight junction structure
will allow for the elucidation of the cofactors affecting the reliability of butyrate as a clinical treatment tool.
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Introduction
Acetate, propionate, and butyrate are the three ma-
jor short-chain fatty acids (SCFA) produced during
bacterial carbohydrate fermentation.1,2 Butyrate is
the least abundant but also the most dynamic of
these three acids, varying from ∼5% to more than
20% of total fermentation acids.3 Maximum bu-
tyrate fermentation is achieved when degradable
fiber and degradable starch coincide in a balanced
way (see next section), whereby butyrate might be
considered a signal molecule for balanced bacterial
growth. The butyrate signal is apparently received
and utilized by the mammalian host to adapt gas-
trointestinal functions to the growth of the bacterial
community (Fig. 1).4,5
Some of the gastrointestinal effects of butyrate
have clinical implications. For example, butyrate
induces epithelial proliferation in normal intesti-
nal tissue6,7 but decreases cell proliferation, in-
creases apoptosis, and stimulates cell differentiation
in colonic cancer cells,8–12 which may minimize the
incidence and progression of colon cancer.4,9,13 Bu-
tyrate also stimulates NaCl absorption in the rat
distal colon14,15 and inhibits the prosecretory ac-
tion of several cAMP-generating secretagogs, which
can be beneficial in the treatment of diarrheal dis-
orders.8,14 Finally, butyrate may improve the bar-
rier function of gastrointestinal epithelia16,17 and
thus ameliorate those diarrheal disorders that are
sustained by barrier failure, for example, inflam-
matory bowel disease (IBD).8,18 Due to the great
importance of IBD, this last aspect of butyrate ac-
tion is receiving increasing attention and will be
the focus of this review. The main intention is to
analyze the current knowledge on the effect of bu-
tyrate on the paracellular tight junction (TJ) barrier
and the molecular events that link butyrate gen-
eration by luminal microbes to an improved TJ
structure.
doi: 10.1111/j.1749-6632.2012.06553.x
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Figure 1. Effects of butyrate in the gastrointestinal tract. Acetate, propionate, and butyrate are produced bymicrobes in fermenta-
tive organs. All three acids have beneficial effects for gut health by stimulatingmucin release inmucosecretory organs (1), increasing
mucosal blood flow (2), the generation of an acidicmilieu (3), and also by stimulation of electrolyte andwater absorption (4).While
butyrate is already more potent than acetate and propionate for some of these effects (e.g., 2 and 4), it has additional beneficial
effects that are either attributed to the specific utilization of butyrate for epithelial cell metabolism (5) or to butyrate-inhibited
histone deacetylation. The latter effect is involved in the regulation of cell proliferation, differentiation, and apoptosis (8) that is
critical in the prevention of colon cancer, as well as the anti-inflammatory (6) and barrier-preserving actions (7) that are critical in
the prevention and therapy of IBD.
In an attempt at interspecies comparison, the
analysis not only includes butyrate effects in the
large intestine but also butyrate generation and ef-
fects in the forestomach of ruminants. The rumen is
interesting for comparative research because partly
different concepts of butyrate action have been pos-
tulated for this gastrointestinal compartment.
Fermentation conditions favoring
microbial butyrate production
Microbial and biochemical presuppositions of
butyrate fermentation
Acetate is the dominating SCFA under almost all
fermentation conditions and is always present in
the highest concentration relative to other SCFA
in ruminal fluid19,20 and intestinal contents.19,21
The percentage of acetate is highest when the rate
of carbohydrate degradation is slow.19 In situa-
tions where there is abundant supply of rapidly
fermentable carbohydrates, such as starch or sug-
ars, fermentation end-product accumulation shifts
toward propionate, and if such excessive fer-
mentation conditions persist, including increased
acidity, lactate production and accumulation is
promoted.22
Butyrate production and accumulation, on the
other hand, seems to rise when high-fiber degrad-
ability and high availability of nonstructural car-
bohydrates coincide. This may be related to the
use of acetate as a precursor for butyrate synthesis
under conditions where lactate fermentation could
occur.23 Under those conditions, lactate-producing
bacteria like Butyrivibrio fibrosolvens may utilize ac-
etate directly for butyrate production via butyryl-
CoA/acetate-CoA transferase rather than through
the conversion of two acetyl-CoA molecules to
acetoacetyl-CoA.24 The replenishing of NAD+ via
the butyryl-CoA/acetate-CoA pathway has signifi-
cant energetic benefits for the involved bacteria.25
These bacteria are strictly anaerobic, Gram-positive
firmicutes and include Faecalibacterium prausnitzii,
Butyrivibrio fibrosolvens, Eubacterium rectale, Rose-
buria faecis, and Eubacterium hallii.25–27
Nutritional modulation of butyrate fermentation
While the biochemistry of butyrate production
is rather well understood,25 achieving elevated
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butyrate concentrations in digesta contents is not
as easily achieved. In this regard, the rumen is a
comparatively simple model because nutrients are
directly introduced into this compartment without
priormodulation by small intestinal absorption. An
analysis of a large data set for ruminal metabolism
showed positive correlations of butyrate production
with the sugar and fermentable neutral detergent
fiber contents of the diet.28 Dietary lactose addition
appears to be a particularly efficient measure to in-
crease the molar proportion of butyrate in ruminal
fluid.29,30
In monogastric species, dietary sugars usually do
not reach the large intestine due to small intestinal
digestionandabsorption.Alternatively, solublefiber
in combination with slowly degradable starch (e.g.,
corn starch) appears to promote large intestinal bu-
tyrate production. Rehman et al. fed chicks a basal
diet (control) primarily consisting of corn and soya
combined with either additional inulin, sucrose, or
the combination of inulin and sucrose. Their study
revealed that providing inulin or inulinwith sucrose
increased cecal butyrate concentration relative to
the control, while sucrose alone failed to increase
butyrate concentration.31 Similarly, Metzler-Zebeli
et al. observed increasing butyrate concentrations in
the stomach, caecum, and colon of young pigs when
supplementing a corn starch–based diet with high
amounts of-glucan.32 These results underline that
the coincidence of easily fermentable fiber and non-
structural carbohydrates are a common prerequisite
for high rates of butyrate fermentation. However,
the nutritional strategy to achieve such conditions
has to consider the site of digesta fermentation.
Role of butyrate for barrier function of
mucosecretory gastrointestinal mucosa
Butyrate and IBD
Beneficial effects of butyrate have been suggested
in acute gastroenteritis, cholera, congenital chloride
diarrhea, and, most often, in IBD.8 The special con-
sideration of butyrate in IBD could be linked to
the prominent involvement of TJ lesions in this dis-
ease complex. The two types of IBD, Crohn’s disease
(CD) and ulcerative colitis (UC), are characterized
by leak flux diarrhea with loss of plasma/interstitial
fluid into the gut lumen due to an insufficient TJ.
The main feature of UC is a reduction in the num-
ber of TJ strands,33 while CD additionally involves
TJ breaks.34
The ongoing inflammation has been suggested to
be a crucial factor triggering TJ leakiness in IBD.35
On the other hand, it is well known that butyrate
enemas can alleviate inflammation in patients with
UC.36 In an attempt to verify the positive effects
of butyrate on the colonic barrier in IBD, Venka-
traman et al. harvested colonic epithelia from the
rat model of IBD, dextran sulfate sodium (DSS)–
induced colitis. Butyrate treatment of those isolated
colonic sheets led to a recovery in transepithelial
resistance (Rt), which was ascribed to a preserva-
tion of TJ integrity and inhibition of TNF- re-
lease.37 Other studies supported this assumption by
demonstrating that butyrate inhibits the release of
TNF-38 and IL-13, the latter being a key effector cy-
tokine of UC.39 Common to both TNF- and IL-13
is their ability to upregulate the expression of the TJ
molecule claudin-2.40 Claudin-2 is a cation-selective
pore41 that is also upregulated in patients with IBD,
where it explains at least part of the disturbances
in barrier function.35 One major effect of butyrate
is to downregulate claudin-2 expression, as shown
by microarray analysis in butyrate-treated colonic
epithelial cells.42 This suggests a relationship be-
tween the alleviation of inflammation by butyrate,
the downregulation of claudin-2, and the improve-
ment of barrier function.
Another study demonstrated a decrease of bu-
tyrate absorption in DSS mice and patients with
IBD. This was mediated by a reduced expression of
the butyrate transporter, monocarboxylate trans-
porter (MCT-)1. A similar reduction in MCT-1
expression could be induced by TNF- in HT-29
cells.43 These findings support an alternative con-
cept in which inflammation during IBD initially
targets on MCT-1 to decrease butyrate uptake. The
low intracellular availability of butyrate would, sub-
sequently, result in a loss of the regulatory depres-
sion of claudin-2 expression by butyrate. However,
further experiments are needed to clearly delineate
the sequence of events that underlie the effects of
butyrate on the TJs, especially on claudin-2 expres-
sion.
Influence of butyrate on barrier function
and TJ integrity
While many studies see the merit of bu-
tyrate treatment on TJ integrity mainly in its
immune-modulatory and anti-inflammatory ac-
tion, in vitro studies showed that barrier function
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of intestinal epithelial cells can also be enhanced
by butyrate in the absence of concurrent immune
stimulation. Nevertheless, the results are equivocal.
While butyrate promoted a higher Rt and a reduced
mannitol permeability in Caco-2 cells,16 a study by
Suzuki et al. showed a short-term increase in Rt in-
duced by amix of SCFA, but not of butyrate alone.44
Those discrepanciesmay depend on othermodulat-
ing factors and on the dose of butyrate. With regard
to the latter, Peng et al. observed an increased Rt in
Caco-2 cells after treatment with 2mmol/L butyrate
and attributed this effect to a reorganization of the
TJ molecules ZO-1 and occludin via activation of
the AMP-activated protein kinase (AMPK).17 How-
ever, higher concentrations of butyrate (8 mmol/L)
decreased Rt, which was associated with a marked
increase in the apoptosis level of Caco-2 cells.45
The ability of butyrate tomodulate TJ protein ex-
pression was also demonstrated in noncolonic cell
models. For example, Harten et al.46 showed a re-
stored epithelial barrier after sodium butyrate treat-
ment in a tumor suppressor gene VHL-defective
renal epithelial cell line that normally shows dis-
rupted TJ structure. The protein concentrations
of E-cadherin, occluding, and claudin-1 were in-
creased after butyrate treatment, and TJ labeling for
ZO-1, occludin, and claudin-1 was restored. These
effectswere assumed tobe linked to adecreasedHIF-
1 expression and an ability of butyrate to act as
histone deacetylase inhibitor (HDACi).46 Further-
more, butyrate also upregulated cingulin, ZO-1, and
ZO-2 in Rat-1 fibroblasts, cingulin in COS-7 cells,
and cingulin and occludin in HeLa cells.47 The au-
thors also attributed the results to an HDACi action
of butyrate.47
Regulation of cell processes by butyrate
acting as HDACi
As already indicated in the previous section, bu-
tyrate may influence cell processes based on its ac-
tion as an HDACi.12,47,48 In many cases, this leads
to hyperacetylation of histones that is followed by
increased gene expression. On the other hand, a
decrease in histone acetylation by butyrate, espe-
cially in downregulated genes, could also be demon-
strated.49 Either way, gene regulation by butyrate is
very often the result of changes in histone acety-
lation. For example, in the gastric cancer cell line
HGC-27, butyrate and the known HDACi tricho-
statin A (TSA) both enhanced vitamin D–induced
apoptosis by upregulating the gene PTEN. This was
based on an increased histone acetylation level at
the PTEN-promoter, which promoted the binding
of the transcription factor Egr-1.50
Transcriptional regulation of gene expression by
butyrate also plays an important role in cell dif-
ferentiation. Gaschott et al. showed a synergism
between butyrate and vitamin D receptor (VDR)
activation on cell differentiation in the colon can-
cer cell line Caco-2.51,52 Cell differentiation implies
the expression of TJ proteins in intestinal epithelial
cells.53,54 So far, however, no direct link has been
established between the expression of the vitamin
D receptor and the expression of TJ proteins in the
intestine. Nonetheless, butyrate action as HDACi
seems to play a role in the regulation of TJ pro-
tein expression. For example, claudin-1 overexpres-
sion induced by increased histone deacetylation is
linked to dedifferentiation and increased invasion in
colon cancer. Claudin-1 overexpression can be re-
versed by butyrate or TSA,which decrease claudin-1
mRNAhalf-life time through their HDACi action.55
Moreover, the downregulation of claudin-2 by bu-
tyrate mentioned earlier in this review42 depends
on a reduced binding affinity of transcription fac-
tors within the claudin-2 promoter.56 It has been
recently shown that TSA and butyrate similarly de-
creased claudin-2 expression in an intestinal cell
line, which points to the possibiliy that this butyrate
effect may also be dependent on altered histone
acetylation.56
Role of butyrate for barrier function
of cutaneous gastrointestinal mucosa
The forestomach as a model
Although current research on the interaction of bu-
tyrate with epithelia is focused largely on the colon,
far larger quantities of SCFA are produced in cer-
tain species that ferment forages in a forestomach,
with production of butyrate alone estimated at ap-
proximately 5–10 mol/day in high-yielding dairy
cows.2,3,19 Accordingly, both the transepithelial ab-
sorptionof SCFAand the intraepithelialmetabolism
of butyrate were first discovered in the forestom-
achs of ruminants.2,57,58 Comparative research on
forestomach epithelia may thus lead to valuable
clues in understanding the general principles of bu-
tyrate action.
In contrast to the colon, the forestomachs
are covered with multilayered stratified squamous
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epithelia, the proliferation of which leads to in-
creases in papillae length and in the number and
composition of cell layers.59–61 The influence of bu-
tyrate on epithelial growth and differentiation can
be observed in milk-fed ruminants, who are born
with a rumen that is nonfunctional and initially by-
passed until transition to a grain or forage based diet
occurs. Butyrate was identified as a key stimulus to
initiate growth anddifferentiation of the rumen into
the mature absorptive organ;62–64 however, a num-
ber of hormonal mediators (glucagon-like peptide
2, insulin, insulin-like growth factor 1) appear to be
involved as cofactors.60,65–69 Interestingly, the me-
diation of butyrate effects via hormonal mediators
has been intensively discussed for the rumen but
has rarely been considered for the large intestine.7
In vitro and without any hormonal stimulus, bu-
tyrate itself has antiproliferative action on primary
cultures of ruminal epithelial cells.65,66,68
Butyrate and the forestomach barrier
A current limitation on attempts to delineate the
effects of butyrate on the forestomach barrier is
that knowledge of its functional organization is far
less advanced than that concerning monolayered
gastrointestinal epithelia. Due to the multilayered
structure of forestomach epithelia, a separation into
a clearly distinct apical and basolateral domain ap-
pears too simplistic.70 Instead, at least two func-
tional barriers emerge. The first barrier is that of the
uppermost stratum corneum, the keratinocytes of
which are thought to forma loosephysical boundary
thatmay serve as an apicalmicroclimate,71 with cells
possibly loosely interconnected by claudin-7.72 The
second barrier is that of the stratum granulosum,
which clearly shows the highest incidence in mor-
phological correlates of occluding junctions,70,73,74
while staining for claudin-1, claudin-4, ZO-1, and
occludin can be observed.70,72 Staining intensity
for claudin-4 drops sharply within the stratum
spinosum toward the basal layer, whereas claudin-
1 and occludin persist down to the stratum basale.
Notably, and in contrast to the findings inmonolay-
ered epithelia, attempts to demonstrate the presence
of the leaky claudin-2 via immunohistochemical
staining, PCR, or Western blot in tissues and cul-
tured cells of the rumen and other forestomach
compartments have so far been unsuccessful.72 Pos-
sibly both due to a lack of claudin-2 and due to
the peculiarities of their multilayered organization,
forestomach epithelia appear to be relatively tight,
allowing the absorption of ions against formidable
gradients.75–77 There is no indication that SCFA in
general,78–80 or butyrate in particular (Penner et al.,
unpublished data), can upregulate what is already
a formidable barrier, although they may enhance
the absorptive capacity of the epithelium79,81,82 and
its ability to withstand osmotic challenges78 and to
metabolize butyrate.80,83,84
Instead, and in conjunction with decreasing lu-
minal pH, rising concentrations of butyrate are
suspected to be a detrimental factor for the
forestomach barrier in a condition known as ru-
minal acidosis.81 Clinicians expect symptoms rang-
ing from decreased food intake to severe ruminal
inflammation with liver abscesses and immunolog-
ical manifestations.85,86 Histologically, rapid struc-
tural changes of the epithelium are observed with
a decline in cellular junctions, sloughing of the
stratum corneum and a thinning of all underly-
ing epithelial layers.87 Chronic exposure leads to a
thickening of the stratum corneum at the expense of
the stratum granulosum,88,89 suggesting profound
alterations in barrier structure in this pathologi-
cal situation. While butyrate is thus essential for
the differentiation and maturation of the forestom-
achs into organs of impressive absorptive capacity,
there is considerable reason to assume that excessive
amounts of butyrate may be toxic, especially when
coinciding with low luminal pH.
Future perspectives
Butyrate is an importantmetabolic signal in the gas-
trointestinal tract with a proven role for the tight-
ness of the epithelial barrier. The latter makes it a
promising tool in the treatment of gut disorders like
IBD. However, butyrate effects are variable andmay
depend on the butyrate concentration, pH, the dif-
ferentiation state of affected cells and on confound-
ing indirect effects of butyrate due to altered profiles
of (or sensitivity to) hormones, growth factors, and
inflammatory mediators. A better understanding of
these complex interactions and the related molecu-
lar events, as well as a better understanding of the
conditions favoring microbial butyrate production,
are necessary to improve the therapeutic usability
of butyrate. To this end, comparative research in
the forestomach of ruminants is suggested to be of
value for delineating primary butyrate actions from
cofactor-dependent effects of butyrate.
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